chrisvoncsefalvay/vaers-outcomes huggingface dataset:
81 y/o lady in excellent health experienced severe dizziness and profound weakness started the evening after vaccine was received. This persisted with progression of nausea and loss of appetite. So bad, she declined the second vaccine. Unable to raise hands to fix her hair, with in a year she was unable to do her own finances anymore.  By late November 2022, when seen by me, her legs were tremoring when standing from sitting, unable to touch finger to nose or alternate palms on her thighs. Cancer was diagnosed and the oncologist speculated 6 mos survival w/o treatment, 2 years with treatment but she was dead 2 weeks later.  Rapid neurologic decline in 1 -1/2 years.  She just stopped breathing 12/2/2022. This was not typical of her cancer, nor typical of dementia- it was much faster.
AFTER THE SHOT, SHE DEVELOPED NAUSEA, BUT NO VOMITING. THEN PATIENT DEVELOPED BODY ACHES. ALSO DEVELOPED SWELLING AT THE INJECTION SITE. BODY ACHES, NAUSEA AND HEADACHE AT TIME OF ER VISIT (3-4 DAYS AFTER VACCINE). IMPROVED WITH BENADRYL/PAIN/NAUSEA MEDS.
raised circular red area surrounding the injection site on the left shoulder; raised circular red area surrounding the injection site on the left shoulder; sustained itching and soreness; sustained itching and soreness; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the left arm also reported as left shoulder, on an unspecified date (Batch/lot number not reported), as dose 1, single, for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, approximately 1 week following the vaccination, the patient experienced raised circular red area surrounding the injection site on the left shoulder. On an unspecified date, the patient experienced sustained itching and soreness. The events took place after vaccination. The outcome of the event raised circular red area surrounding the injection site on the left shoulder was unknown, and sustained itching and soreness was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Severe pain and swelling in hands.  Weakness. Falling. Flu like feeling.
Limp for a few days starting 9/3/04 xrays negative. Limp resolved with treatment in a few days.
no adverse reactions or side effects; vaccination with pneumococal vaccine yearly since 2000-2019; This spontaneous report as received from a lawyer and a consumer via a Plaintiff Fact Sheet regarding a case in litigation (MARRS 2002USA008825) refers to an approximately 61 year old female patient. On an unspecified date in 2001, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route and lot # not reported). The patient stated that she was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) yearly since 2000. No adverse reactions or side effects were reported.; Sender's Comments:  US-009507513-2002USA008825:
No additional AEs reported; Nurse reports that an expired dose of V ARlV AX was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug or allergy history. No concomitant therapies were reported.      On 23-FEB-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S004862 and expiration date since it makes match with the autopopulated expiration date 18-FEB-2021), 0.5 milliliter (strength, vaccination scheme, anatomical site of injection, route of administration and indication were not reported).        No additional adverse event reported.
It was Itchy; Lump under the arm; It was red; It was hot; Arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (It was hot), VACCINATION SITE PRURITUS (It was Itchy), VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE SWELLING (Lump under the arm) and VACCINATION SITE ERYTHEMA (It was red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 17-Feb-2021, the patient experienced INJECTION SITE WARMTH (It was hot), VACCINATION SITE SWELLING (Lump under the arm) and VACCINATION SITE ERYTHEMA (It was red). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (It was Itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. On 09-Feb-2021, VACCINATION SITE PAIN (Arm was sore) had resolved. On 24-Feb-2021, INJECTION SITE WARMTH (It was hot), VACCINATION SITE PRURITUS (It was Itchy), VACCINATION SITE SWELLING (Lump under the arm) and VACCINATION SITE ERYTHEMA (It was red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information for the events included diphenhydramine. No relevant concomitant medications were reported.
Child returned to clinic within 30 minutes with wheezing, L eye swelling, and pruritis. Albuterol and Benadryl administered, with complete resolution of symptoms. No hypotension, vomiting associated. Child monitored for 30 min prior to discharge and at baseline when left clinic.
Syncope ... lasted 5-10 seconds. Symptomatic treatment for 5 minutes. No medical treatment sought.
Terrible chills that lasted for 6 days.  Chronic dizziness, extreme fatigue. loss of appetite. ear pain. headache.
Redness, swelling, tenderness and itching at the injection site 7 days after receiving the first dose.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for four patients. This is first of four reports. A patient of unspecified age ethnicity and gender received fifth dose of PREVNAR 13, via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient did not seroconvert after the fourth administration of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein). On an unspecified date, the patient experienced after the 5th dosage, titers increased significantly. It was also reported that checking titers was necessary after a complete immune work up due to frequent illnesses. Outcome of the event was unknown. Information on lot number, batch number and expiration date has been requested. Sender's Comments: Linked Report(s) : US-PFIZER INC-2018194075 same reporter, product and event, different patient; US-PFIZER INC-2018194076 same reporter, product and event, different patient; US-PFIZER INC-2018194077 same reporter, product and event, different patient.
Per Conversation with patient and confirmation with pharmacy, patient received 2 doses of the MODERNA COVID 19 vaccine on 3/5/21 and 4/2/21 for a total of 4 vaccines received by the patient. One series from our pharmacy and one from a different pharmacy. From the conversation, it appears patient believes they received pfizer and moderna but was hard to communicate clearly with patient and patient was getting frustrated. Patient did state that he had no side affects from receiving twice the dose.
At approximately 4am on Sunday 11/13 (~6 days post vaccination) I woke up with right knee pain and swelling. Later that same day, the pain and swelling spread to my bilateral shoulders, bilateral knees, bilateral ankles, bilateral wrists, and finger joints. I also developed welts on my skin when anything touched it, as well as a diffuse red macular rash on my chest on neck. I felt feverish but did not check my temperature. On Tuesday 11/15 I went to the ER and was diagnosed with a suspect delayed hypersensitivity reaction to the booster. I was given IV fluids, steroids, and antihistamines. I was started on a steroid and antihistamine course and symptoms are resolving at the time of writing this report, but are still moderately present. The ER I presented to was ER. The booster I received on 11/7 was my 4th vaccination overall -- my others were the Pfizer vaccines done on 12/20/2020, 1/6/2021, and 10/13/2021.
5/19/2004 Both mother and paternal grandmother state child had last shots 3/18/04. He went home and took a nap. When he awoke around 5 or 6PM he began screaming and they could not comfort him. Both mother and grandmother states the child would not be consoled. Mother called the doctor the next day, but the doctor did not seem to be worried about the screaming at that time. When they could not get the child to settle, they took pt to the emergency room for evaluation. The emergency room doctor could not find anything physically wrong with the child and told the parent they felt his screaming was a result of the shots. He continued with the behavior until Saturday, 3/20/04 at 11PM when he went to sleep and when he awoke was fine. He has had not further episodes of the screaming. He did not run a fever. Grandmother stated he did seem to be shaking once during the event, but not as in a seizure. Mother did not mention this.
This case was reported by a physician via call center representative and described the occurrence of injection site irritation in a female patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced injection site irritation, injection site lump, pruritus, nausea and eye swelling. On an unknown date, the outcome of the injection site irritation, injection site lump, pruritus, nausea and eye swelling were unknown. It was unknown if the reporter considered the injection site irritation, injection site lump, pruritus, nausea and eye swelling to be related to BEXSERO. Additional details were reported as follows: This case was submitted as an after hours call. This case was reported by a friend of the family. The age at vaccination was not reported. The patient was a young lady (college going) who had an adverse reaction. The patient had an irritant knot below the injection site. The patient also had another knot at a remote location. The reporter asked to give a call and stated that, it seemed like a minor reaction and the patient was not reporter's patient.
This spontaneous report as received from a nurse practitioner refers to multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored GARDASIL (lot # and expiration date unknown). The excursion temperature was 33.8 degree Fahrenheit. The excursion time frames were 1 hour 59 minutes and 1 hour and 43 minutes. The temperature was back in range. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Immediate confluent erythema on lower extremities and irritability. Lasted approximately 15-20 minutes.
Then, my hair is straight, it ain't no more, it will curl up and it just curls up; 103.1 fever; freezing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08May2021 (Lot number: EW0158) at the age of 77 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Verbatim: gall bladder out" (unspecified if ongoing), notes: Verbatim: gall bladder out; "Verbatim: Kidney stones", start date: Feb2021 (unspecified if ongoing), notes: Verbatim: Kidney stones; "Verbatim: Diabetic" (unspecified if ongoing), notes: Verbatim: Diabetic; "Blood pressure" (unspecified if ongoing), notes: Blood pressure; "so her arteries don't block up" (unspecified if ongoing), notes: so her arteries don't block up; "for heart attacks" (unspecified if ongoing), notes: for heart attacks; "Sugar" (unspecified if ongoing), notes: for sugar, diabetes; "Verbatim: Blockages" (unspecified if ongoing), notes: Verbatim: Blockages. Concomitant medication(s) included: MINOXIDIL taken for blood pressure abnormal (ongoing); ROSUVASTATIN taken for coronary artery disease (ongoing); METOPROLOL TARTRATE taken for blood pressure abnormal (ongoing); AMLODIPINE BESILATE taken for blood pressure abnormal (ongoing); GLIPIZIDE taken for diabetes mellitus, blood glucose abnormal, start date: Feb2021 (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] taken for myocardial infarction, start date: Feb2021 (ongoing); QUINAPRIL (ongoing). Vaccination history included: Bnt162b2 (1st dose, LOT: ER8727, Anatomical Location: left arm), administration date: 17Apr2021, when the patient was 77 years old, for Covid-19 immunisation, reaction(s): "103.1 fever", "hair texture abnormal", "hair loss", "freezing". The following information was reported: HAIR TEXTURE ABNORMAL (non-serious), outcome "unknown", described as "Then, my hair is straight, it ain't no more, it will curl up and it just curls up"; PYREXIA (non-serious), outcome "unknown", described as "103.1 fever"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "freezing". The patient underwent the following laboratory tests and procedures: body temperature: 103.1, notes: She had a 103.1 fever the next day, after both shots.  No follow-up attempts are possible. No further information is expected.
MMR vaccine given in the wrong location. Needle Insertion was inferior to the right deltoid, midline with the acromion process, needle was angled superior and distal. Vaccine solution injected too close to the dermis, red intradermal wheel seen and palpated. Immediate blotchy, reddened localized reaction which resolved after cold compress and approximately 15 minutes. Red intradermal wheel resolved later that evening. Continued consolable at times fussiness seen currently. BENADRYL given after local reaction resolved, reddened wheel still visible. I told the nurses and doctor I believed the vaccine was administered wrong immediately. The nurse said I could leave the office, stating "it's just a little red" "it's just a local reaction". I stated I wanted to wait and breastfed and re-assess in a few minutes. Then the doctor came in. I also told her I  believed it was administered wrong, her response was, "They (referring to the nurses) give these all day long". Then wanted to given BENADRYL. I feel my concern was not addressed even though the doctor and nurses saw where the injection site was due to the band aide placement. I asked to speak with the manager at check-out who was not available but did call the next day. The manager was rude and insisted multiple times I send her a picture of my son with his shirt off to file a complaint. I declined. The picture was taken on my phone at the request of Dr., to show the allergist, while in the office with Dr. and the nurse hold son on the exam table. It shows the wrong insertion site/band aide placement and reddened wheel location.
Severe headache with fatigue started 04/12/2021. 04/14/2021 tightening in chest. went to local urgent care clinic for rapid test and treatment. EKG done also. Showed abnormal.,sent to local ER. Diagnosed with possible STEMI. Ems ride to  north cath lab. Heart cath diagnosis of Pericarditis.
My son was either seizing or stroking. His movement was not normal compared to usual movement. Prior to this event, he would coo and make eye contact with me. He reached his 2 month mile stones. After this event, he stopped cooing and was not as vocal. Paramedics were called and the looked him over. I showed them my video evidence of the seizure/stroke. They looked him over and said whatever it was passes and seems fine now.
Patient was baseline but very sleepy all afternoon after vaccinations. At 7:30pm mom found patient on floor unresponsive face up, blue lips, purple face, head and hands were shaking but apparently breathing on his own. Patient taken to local hospital. Limited workup completed. No acute intracranial processes found but imaging was poor due to movement. Patient continued to be unresponsive, however did scream upon IV start. Pupils were dialated and very sluggish. Still breathing spontaneously and had one episode of emesis. Was transferred by helicopter to hospital at approximately 2340 on 3/5/14. Hospital course: On arrival GCS = 9, Assessment included encephalopathy, head twitching, teeth grinding for 5 seconds. Concern for seizures and progression of encephalopathy and presumed meningitis. Neurology recommended MRI/MRA/MRV and loaded with Keppra and an EEG. Patient received ceftriaxone and acyclovir for presumed meningitis. EEG showed severe, diffuse encephalopathy.
Information has been received from a consumer concerning a child patient who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed breakthrough chicken pox, in spite of being vaccinated with varicella virus vaccine live. This was also described as a case of slight breakthrough varicella. The patient was exposed to varicella when the patient's father developed shingles. It was unknown if medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  STABLE ANGINA ACUTE NON ST ELEVATION MI
Patient received flu shot at 1:30 PM on 10/23/02. About 4PM of that day, reported developing hives. Called to report. Told to take Benadryl for relief. Seen by doctor 10/28/02; still complains of occasional itching. No rash SOB, etc at visit. To continue Benadryl.
Initial report received on 19 July 2012 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a 21-month-old male subject (initials not collected) was identified by the investigator based on review of data from Electronic Disease Surveillance electronic database. The subject had received 3 doses of PENTACEL; lot number C3658AA received on 29 October 2010, lot number C3748AB received on 30 December 2010, and lot number C3755AA received on 16 June 2011 (routes and sites of administration not reported). The subject developed cold-like symptoms and cough on 18 June 2012, approximately one year after the last dose. On 20 June 2012 the subject developed a paroxysmal cough without whoop. The subject also experienced sleep disturbance. Laboratory testing included positive PCR on 21 June 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 21 June 2012 for five days. The subject was not hospitalized. At the time of final contact on 09 July 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 21 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
24-48 hours post vaccination of Tdap (r delt) and Hep B (left Delt) pt became feverish, 104 deg, shakes, chills, in bed with malaise. Artus reaction in Right arm. Pt self treated R arm with "Celestial Seasons" muscle balm, which made it worse-contained menthol.
Information has been received from a healthcare worker referring to unknown number of patients of unknown age and gender. Information about patients' concomitant medications, concurrent conditions and medical history was not reported. The healthcare worker reported that on unspecified dates since 15-OCT-2015 the patients were vaccinated with doses of RECOMBIVAX HB (dose and route not reported, lot # L027733 with expiration date 13-SEP-2017), which were exposed to the temperatures outside of the recommended range (temperature: 31F and time frame: 838 hours 59 minutes). The reporter was not aware of any adverse effects. This is one of several reports received from the same reporter. Additional information has been requested.
pt said she felt dizzy and was going to faint. her heart rate was high than normal. she asked to call 911.  911 arrived and gave her zofran and check her oxygen, bp and sugar. she felt better after . she refused to go to hospital and she called her friend to come and pick her up. she assured pharmacy that she is filling fine before she leave pharmacy
Extreme swelling - redness - sore.  On Sep 5th went to Dr. Several days concerned about cellulitis. 5 days of clindamycin 75 mg. Loss of appetite - lost 8 lbs. Weak feeling, red streaks from shot area to elbow. Saw Dr.
sore arm; This is a spontaneous report from a contactable consumer (patient). A 55-years-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot number: EN6208, expiration date: 30Jun2021) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included high blood pressure she has had this condition for 3 or 4 years and arthritis. Concomitant products included patient has been on Celebrex at a dose of 200 mg twice a day for about 2 weeks. Patient was taking Celebrex for arthritis and lisinopril with HCTZ 20mg/25mg 1x/day for high blood pressure, she has been taking this for 3 or 4 years. It was reported that after the first shot the patient experienced sore arm. The outcome of event was unknown.  No follow-up attempts are needed. No further information was expected.
When he got the shot he felt hot and sweaty and it cleared and a few day later he had a bad reaction having  chills, chest pains, pains in left arm and on left side,  and nausea and lower back pain
Extreme soreness of the arm, unable to sleep on that arm, or raise above the head.
Large area of warmth, induration, erythema around site of Menactra administration (right deltoid).
received the vaccination at 0900 and has since developed bluing of the fingertips, chills, fever of 101 and tingling of the fingers. She has taken 2 Tylenol for her fever. Advised would recommend eval to HCF for symptoms. They will go to Medical Center. Followed up with caller who adv that they went to the ED. She was evaluated and discharged home.
Information has been received from a physician concerning a female in 40s who was vaccinated with the first and second dose of PNEUMOVAX 23 within one year. After the second dose of PNEUMOVAX 23 the patient developed reaction. The patient had sought unspecified medical attention. At the time of the report, the patient's status was unknown. Follow-up information has been received from a physician concerning a patient with no illness at time of vaccination who was vaccinated with the first and second dose of PNEUMOVAX 23 within one year (per the patient's report) apart. Concomitant vaccination included influenza virus vaccine (unspecified). With the second dose of PNEUMOVAX 23, the patient experienced a large injection site reaction. There was no relevant diagnostic test performed. At the time of the report, it was unknown if the patient had recovered from the event. Additional information has been requested.
Information has been received from a physician concerning an adult pt who on 24Oct05 was vaccinated with an IM 0.5mL first dose pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). On 25Oct05 the pt was diagnosed with cellulitis. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
pt c/o pain in rt eye then lt eye; 9AM 29JUN94 inc crying w/eye pain intermittantly 9AM-12noon; vomited 145PM 29JUn93 then again 4PM; inc sleeping all day 29JUN94;